Latest Intravenous immunoglobulin Stories
WASHINGTON, May 25, 2011 /PRNewswire-USNewswire/ -- The Immune Deficiency Foundation (IDF) applauds Representatives Kevin Brady (R-TX) and Doris Matsui (D-CA) and Senators John Kerry (D-MA) and Lamar Alexander (R-TN) for introducing H.R. 1845 and S. 960, both entitled the Medicare IVIG Access Act.
CINCINNATI, April 4, 2011 /PRNewswire/ -- CarePoint Partners (CarePoint) today announced at the National Home Infusion Association Annual Conference in Orlando, Florida that it has acquired Infusion Technologies, a provider of home infusion therapies including antibiotics, IVIG, nutrition, the associated nursing services and a variety of specialty injections, with locations in North Miami and Tampa.
KING OF PRUSSIA, Pa., March 21, 2011 /PRNewswire/ -- Data presented by CSL Behring today suggest that treatment with higher dose HizentraÂ® (IgPro 20) correlates with reduced risk of infection and missed school or work among patients with primary immunodeficiencies (PI).
KING OF PRUSSIA, Pa., March 19, 2011 /PRNewswire/ -- CSL Behring today announced the development of an innovative pharmacokinetic (PK) model that allows the absorption, distribution, metabolism, and elimination of subcutaneous (SC) immunoglobulin G (IgG) following administration to be simulated with a high degree of accuracy and precision.
LOS ANGELES, Feb. 3, 2011 /PRNewswire/ -- Grifols, Inc. today announced that it has expanded the company's PatientCare Program to offer immune globulins (IVIG) to the Primary Immune Deficiency community (PID).
LOS ANGELES, Nov. 22, 2010 /PRNewswire/ -- Grifols today announced availability of its recently approved FlebogammaÂ® 10% DIF intravenous immune globulin. Grifols is a global healthcare company specializing in bioscience medicines derived from human plasma.
ANAHEIM, Calif., Nov. 18, 2010 /PRNewswire/ -- Crescent Healthcare today announced a planned expansion of their east coast operations in 2011.
RESEARCH TRIANGLE PARK , N.C., Oct. 14 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics (Nasdaq: TLCR) announced today that the U.S.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.